Concepedia

Kathrin Löffler

KL

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

2006

Affiliations

Silence Therapeutics (Germany)(Current)

Silence Therapeutics (United Kingdom)

Kathrin Löffler is an author at Silence Therapeutics (Germany) specializing in pharmacology, rna interference therapeutics, and small interfering rna biology.

Publications per year

2006–2022

8

Publications

8

A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium

Ansgar Santel, Manuela Aleku, Oliver Keil et al. · Gene Therapy · 2006 · 365 citations

, , +16

Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression

Manuela Aleku, Petra Schulz, Oliver Keil et al. · Cancer Research · 2008 · 295 citations · Full text

, , +17

RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy

Ansgar Santel, Manuela Aleku, Oliver Keil et al. · Gene Therapy · 2006 · 184 citations

, , +17

Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models

Ansgar Santel, Manuela Aleku, Nadine Röder et al. · Clinical Cancer Research · 2010 · 102 citations

, , +17

Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease

David A. Rider, Mona Eisermann, Kathrin Löffler et al. · Atherosclerosis · 2022 · 56 citations

, , +16

1–5 of 8